Skip to main content

Find Clinical Trials

Home
Conditions
Parathyroid Diseases

Clinical trial condition

Parathyroid Diseases

Explore clinical trials studying Parathyroid Diseases. Study availability and eligibility vary by location and protocol.

441 public trials 75 recruiting studies

Refine in advanced search Browse all conditions

Parathyroid Diseases trial results

Completed

Recombinant Human rhPTH(1-34) VS Association Alfacalcidol/Hydrochlorothiazide in Severe Primary Hypoparathyroidism

NCT02824718

Conditions: Autosomal Dominant Hypocalcemia OR Primary Hypoparathyroidism Related to Other Cause But Complicated by Hypercalciuria Under Treatment, Endocrine System Diseases, Hypercalciuria, +5 more
Locations: AP-HP Hopital Europeen Georges Pompidou Paris, France

View Trial Details

Completed

Study of Safety and Efficacy of a rhPTH[1-84] of Fixed Doses of 25 and 50 mcg in Adults With Hypoparathyroidism (RELAY)

NCT01268098

Conditions: Endocrine System Diseases, Hypoparathyroidism, Parathyroid Diseases
Locations: Advance Medical Research LLC Lakewood, California, United States

University of Chicago Medical Center Chicago, Illinois, United States

Indiana University School of Medicine Indianapolis, Indiana, United States

Massachusetts General Hospital Boston, Massachusetts, United States

View Trial Details

Completed

A Study to Investigate the Safety and Tolerability of NPSP558, for the Treatment of Adults With Hypoparathyroidism - A Clinical Extension Study in Hungary

NCT01455181

Conditions: Endocrine System Diseases, Hypoparathyroidism, Parathyroid Diseases
Locations: Semmelweis University Medical School Budapest, Hungary

University of Pécs, School of Medicine Pécs, Hungary

University of Szeged Szeged, Hungary

View Trial Details

Completed

Study of rhPTH(1-84) in Japanese Healthy Subjects Compared With Matched Caucasian Healthy Adult Subjects

NCT03150108

Conditions: Endocrine System Diseases, Hypoparathyroidism, Parathyroid Diseases
Locations: Glendale Adventist Medical Center Glendale, California, United States

View Trial Details

Completed

Swalqol in Primary Hyperparathyroidism

NCT03968510

Conditions: Endocrine System Diseases, Hyperparathyroidism, Parathyroid Diseases
Locations: Uşak University Uşak, Turkey (Türkiye)

View Trial Details

Completed

Use of NPSP558 in the Treatment of Hypoparathyroidism

NCT00732615

Conditions: Endocrine System Diseases, Hypoparathyroidism, Parathyroid Diseases
Locations: Mayo Clinic-Scottsdale Scottsdale, Arizona, United States

Advance Medical Research LLC Lakewood, California, United States

Diabetes Associates Orange, California, United States

University of California-San Francisco VA Medical Center San Francisco, California, United States

View all 31 locations

View Trial Details

Completed

The Feasibility of Bilateral Intermediate Cervical Plexus Block for Thyroidectomy/Parathyroidectomy

NCT04905641

Conditions: Endocrine Gland Neoplasms, Endocrine System Diseases, Head and Neck Neoplasms, +8 more
Locations: Faculty of Medicine Siriraj Hospital, Mahidol University Bangkok, Thailand

View Trial Details

Completed

Phase 3 Study of KHK7580 for the Treatment of Hypercalcemia in Patients With Parathyroid Carcinoma or Primary Hyperparathyroidism

NCT03280264

Conditions: Endocrine Gland Neoplasms, Endocrine System Diseases, Head and Neck Neoplasms, +8 more
Locations: Osaka City University Hospital Ōsaka, Japan

View Trial Details

Completed

A Open-label Study Investigating the Safety and Tolerability of NPSP558, a Recombinant Human Parathyroid Hormone (rhPTH [1-84]), for the Treatment of Adults With Hypoparathyroidism - A Clinical Extension Study (RACE)

NCT01297309

Conditions: Endocrine System Diseases, Hypoparathyroidism, Parathyroid Diseases
Locations: Advance Medical Research LLC Lakewood, California, United States

Mayo Clinic Jacksonville Jacksonville, Florida, United States

University of Chicago Medical Center Chicago, Illinois, United States

Indiana University School of Medicine Indianapolis, Indiana, United States

View all 14 locations

View Trial Details

Completed

Study to Assess the Blood Concentrations and Actions of Recombinant Human Parathyroid Hormone (rhPTH [1-84]) When Given Once and Twice Daily to Participants With Hypoparathyroidism

NCT02781844

Conditions: Endocrine System Diseases, Hypoparathyroidism, Parathyroid Diseases
Locations: Providence Clinical Research North Hollywood, California, United States

Indiana University Indianapolis, Indiana, United States

University Of Kentucky School of Medicine Lexington, Kentucky, United States

Crescent City Clinical Research Center, LLC Metairie, Louisiana, United States

View all 15 locations

View Trial Details